ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.
Employees: 1-10
Total raised: $164.44K
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.04.2023 | - | $164.44K | - |
Mentions in press and media 4
| Date | Title | Description |
| 06.05.2024 | Innosuisse funded 45 Start-up innovation projects | With the Start-up innovation project, Innosuisse directly funds high potential science-based projects initiated by Swiss start-ups, giving them a financial boost to propel their market entry. The innovation projects must be based on applic... |
| 15.05.2023 | InnoBooster to accelerate novel solutions with high potential | |
| 05.04.2023 | ASTRA Therapeutics receives funding to develop anti-parasite drugs | |
| 04.04.2023 | ASTRA Therapeutics receives CHF 150,000 to develop anti-parasite drugs | Parasitic diseases like malaria, cryptosporidiosis, and toxoplasmosis affect millions of people worldwide; they also represent a major cause of disease and production loss in livestock and agriculture. Yet, emergent drug resistances as well... |